Sphenopalatine Ganglion Block as Adjuvant to General Anesthesia Regarding the Quality of Surgical Field in Trans-Sphenoidal Endoscopic Hypophysectomy
The Efficacy of Ultrasound Guided Sphenopalatine Ganglion Block as Adjuvant to General Anesthesia Regarding the Quality of Surgical Field in Trans-Sphenoidal Endoscopic Hypophysectomy: A Randomized Controlled Trial
Cairo University
70 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the efficacy of ultrasound guided sphenopalatine ganglion block (SPGB) through the suprazygomatic approach in optimizing the quality of surgical field as well as its effect on postoperative pain relief in patients undergoing transsphenoidal pituitary surgeries under general anesthesia.
Eligibility
Inclusion Criteria3
- Age between 21 and 60 years.
- American Society of Anesthesiologists (ASA) Physical Status I or II.
- Undergoing elective endoscopic trans-nasal resection of pituitary adenoma.
Exclusion Criteria6
- Patient's refusal
- ASA Physical Status III or IV patients
- Patients receiving drugs influencing blood coagulation
- Allergy to any of the drugs utilized in this study
- History of chronic pain therapy
- Inadvertent intra-operative vascular injury
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive sphenopalatine ganglion block (SPGB) using 4 mL of 0.25% bupivacaine combined with 1 mL of dexamethasone.
Patients will receive general anesthesia alone.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07569952